Search

Search Results

##search.searchResults.foundPlural##

The relationship of prostate cancer diagnosed by magnetic resonance imaging/transrectal ultrasound prostate fusion biopsy with standard and adjusted anogenital distances

Feyzi Sinan Erdal, Akif Erbin, Sami Sekkeli, Caglar Dizdaroglu, Rustu Turkay

26-06-2026

https://doi.org/10.4081/aiua.2026.15162

283

Downloads: 203
Diagnostic performance of PI-RADS and PSA density for detecting clinically significant prostate cancer

Walid Shanaa, Ibrahim Alnadhari, Omar Ali, Osama Abdeljaleel, Hana J. Abukhadijah, Ahmad Shamsodini

29-06-2026

https://doi.org/10.4081/aiua.2026.15133

300

Downloads: 214
Cognitive zonal fusion biopsy of the prostate: Original technique between target and saturation

Andrea B. Galosi, Guevar Maselli, Giulia Sbrollini, Gaetano Donatelli, Lorenzo Montesi, Matteo Tallè, Rodolfo Montironi

292-295

30-12-2016

https://doi.org/10.4081/aiua.2016.4.292

2585

Downloads: 1513
Free prostate-specific antigen outperforms total prostate-specific antigen as a predictor of prostate volume in patients without prostate cancer

Sinan Avci, Efe Onen, Volkan Caglayan, Metin Kilic, Murat Sambel, Sedat Oner

1-6

06-04-2020

https://doi.org/10.4081/aiua.2020.1.1

1644

Downloads: 1439
Relevance of prostate cancer in patients with synchronous invasive bladder urothelial carcinoma: a monocentric retrospective analysis

Lucio Dell’Atti

76-79

31-03-2015

https://doi.org/10.4081/aiua.2015.1.76

1925

Downloads: 1155
Predictors of prostate cancer detection in MRI PI-RADS 3 lesions – Reality of a tertiary center

Débora Araújo, Alexandre Gromicho, Jorge Dias, Samuel Bastos, Rui Miguel Maciel, Ana Sabença, Luís Xambre

20-12-2023

https://doi.org/10.4081/aiua.2023.11830

4498

Downloads: 846
MRI/US fusion prostate biopsy in men on active surveillance: Our experience

Vito Lacetera, Angelo Antezza, Alessio Papaveri, Emanuele Cappa, Bernardino Cervelli, Giuliana Gabrielloni, Michele Montesi, Roberto Morcellini, Gianni Parri, Emilio Recanatini, Valerio Beatrici

88-91

22-03-2021

https://doi.org/10.4081/aiua.2021.1.88

1506

Downloads: 842
Do all patients with suspicious prostate cancer need Multiparametric Magnetic Resonance Imaging before prostate biopsy?

Sara Teixeira Anacleto, Joana Neves Alberto, Emanuel Carvalho Dias, Pedro Sousa Passos, Mário Cerqueira Alves

32-36

28-03-2022

https://doi.org/10.4081/aiua.2022.1.32

1178

Downloads: 683
The pathological and clinical features of anterior lesions of prostate cancer: Evaluation in a single cohort of patients

Daniele D'Agostino, Paolo Corsi, Michele Colicchia, Daniele Romagnoli, Gian Maria Busetto, Matteo Ferro, Alessandro Tafuri, Matteo Cevenini, Federico Mineo Bianchi, Marco Giampaoli, Angelo Porreca

23-06-2020

https://doi.org/10.4081/aiua.2020.2.102

1465

Downloads: 941
Outcomes of active surveillance for clinically localized prostate cancer in a middle eastern tertiary care center

Mohammad Hout, Ali Merhe, Nassib Abou Heidar, Jose M. El-Asmar, Wassim Wazzan, Bassel Bachir, Rola Jaafar, Albert El-Hajj, Muhammad Bulbul

385-388

20-12-2021

https://doi.org/10.4081/aiua.2021.4.385

1497

Downloads: 651
Detection rate for significant cancer at confirmatory biopsy in men enrolled in Active Surveillance protocol: 20 cores vs 30 cores vs MRI/TRUS fusion prostate biopsy

Pietro Pepe, Sebastiano Cimino, Antonio Garufi, Giandomenico Priolo, Giorgio Ivan Russo, Raimondo Giardina, Giulio Reale, Michele Barbera, Paolo Panella, Michele Pennisi, Giuseppe Morgia

300-303

30-12-2016

https://doi.org/10.4081/aiua.2016.4.300

2687

Downloads: 1566
Effectiveness of cognitive fusion transrectal ultrasound prostate biopsy when compared with final prostatectomy histology

Ana Sofia Araújo, Joao Serra, Sara Anacleto, Ricardo Rodrigues, Catarina Tinoco, Andreia Cardoso, Mariana Capinha, Vera Marques, Paulo Mota

18-12-2024

https://doi.org/10.4081/aiua.2024.13194

1203

Downloads: 586
Diagnostic accuracy of the Novel 29 MHz micro-ultrasound “ExactVuTM” for the detection of clinically significant prostate cancer: A prospective single institutional study. A step forward in the diagnosis of prostate cancer

Francesco Chessa, Riccardo Schiavina, Amelio Ercolino, Caterina Gaudiano, Davide Giusti, Lorenzo Bianchi, Cristian Pultrone, Emanuela Marcelli, Concetta Distefano, Luca Lodigiani, Eugenio Brunocilla

132-138

28-06-2021

https://doi.org/10.4081/aiua.2021.2.132

2129

Downloads: 1586
MRI/TRUS FUSION guided biopsy as first approach in ambulatory setting: Feasibility and performance of a new fusion device

Daniele D'Agostino, Federico Mineo Bianchi, Daniele Romagnoli, Marco Giampaoli, Paolo Corsi, Alessandro Del Rosso, Riccardo Schiavina, Eugenio Brunocilla, Angelo Porreca

211-217

13-01-2020

https://doi.org/10.4081/aiua.2019.4.211

1655

Downloads: 889
Incremental detection of clinically significant prostate cancer by systematic biopsy outside MRI-targeted lesions during cognitive fusion local anaesthetic transperineal biopsy

Emeka I. Udeh, Nadine Coull, Abdussalam Musbahi, Rotimi David, Richard Akiboye

07-09-2026

https://doi.org/10.4081/aiua.2026.15728

23

Downloads: 20
Can multiparametric ultrasound improve cognitive MRI/TRUS fusion prostate biopsy

Pietro Pepe, Ludovica Pepe, Paolo Panella, Michele Pennisi

23-06-2020

https://doi.org/10.4081/aiua.2020.2.89

1777

Downloads: 1028
Learning curve of a multidisciplinary team for magnetic resonance imaging/transperineal ultrasonography fusion prostate biopsy

Marcello Scarcia, Vincenzo Andracchio, Alberto Piana, Roberto Calbi, Michele Zazzara, Francesco Chiaradia, Antonio Greco, Flavio Sidoti, Gianluca Scarpelli, Pierluigi Rizzo, Guglielmo Mantica, Alessandro Calarco, Rosario Leonardi, Giuseppe Mario Ludovico, Stefano Alba

05-08-2025

https://doi.org/10.4081/aiua.2025.13933

525

Downloads: 583
Pathological issues in biopsy specimens of men with prostate cancer eligible for active surveillance

Roberta Mazzucchelli, Andrea Benedetto Galosi, Antonio Lopez-Beltran, Marina Scarpelli, Liang Cheng, Rodolfo Montironi

314-318

30-12-2014

https://doi.org/10.4081/aiua.2014.4.314

1851

Downloads: 987
The effect of flavonoid and subclasses supplementation on prostate specific antigen, hormonal parameters and prostate cancer risk: a systematic review and meta-analysis of randomized controlled trials

Abdul Azis, Andi Asadul Islam, Haerani Rasyid, Lukman Hakim, Syakib Bakri, Agussalim Bukhari, Andi Alfian Zainuddin

17-04-2025

https://doi.org/10.4081/aiua.2025.13645

1580

Downloads: 2208
Diagnostic efficacy and safety of transperineal prostate targeted and systematic biopsy: The preliminary experience of first 100 cases

Shahbaz Mehmood, Khalid Ibraheem Alothman, Abdulaziz Alwehaibi, Samia Mohamed Alhashim

127-131

28-06-2021

https://doi.org/10.4081/aiua.2021.2.127

1485

Downloads: 834
Perineural invasion in prostate needle biopsy: Prognostic value on radical prostatectomy and active surveillance

Nuno Ramos, Alexandre Macedo, João Rosa, Miguel Carvalho

18-12-2020

https://doi.org/10.4081/aiua.2020.4.330

1669

Downloads: 959
mpMRI PI-RADS score 3 lesions diagnosed by reference vs affiliated radiological centers: Our experience in 950 cases

Pietro Pepe, Giuseppe Candiano, Ludovica Pepe, Michele Pennisi, Filippo Fraggetta

139-142

28-06-2021

https://doi.org/10.4081/aiua.2021.2.139

1702

Downloads: 793
68Ga-PSMA PET/CT evaluation in men enrolled in prostate cancer Active Surveillance

Pietro Pepe, Ludovica Pepe, Marinella Tamburo, Giulia Marletta, Francesco Savoca, Michele Pennisi, Filippo Fraggetta

22-05-2023

https://doi.org/10.4081/aiua.2023.11322

1907

Downloads: 1150
Survival and oncological outcomes for young men (≤55 years) undergoing radical prostatectomy for localized prostate cancer

Shahryar Zeighami, Ali Ariafar, Alireza Makarem, Faisal Ahmed, Mohammadreza Askarpour

23-01-2025

https://doi.org/10.4081/aiua.2025.12658

2331

Downloads: 1269
Multiparametric MRI targeted prostate biopsy: When omit systematic biopsy?

Pietro Pepe, Ludovica Pepe, Vincenzo Fiorentino, Mara Curduman, Filippo Fraggetta

11-11-2024

https://doi.org/10.4081/aiua.2024.12992

1290

Downloads: 714
Prognostic value of neutrophil-to-lymphocyte ratio in mCRPC patients treated with abiraterone, enzalutamide and docetaxel: a retrospective single-center study

Ana Marta Ferreira, André Rego, Vasco Quaresma, Roberto Jarimba, Edgar Tavares da Silva, Pedro Nunes, Arnaldo Figueiredo

07-08-2026

https://doi.org/10.4081/aiua.2026.15630

119

Downloads: 78

1 - 26 of 26 items

Search

Search Results

The relationship of prostate cancer diagnosed by magnetic resonance imaging/transrectal ultrasound prostate fusion biopsy with standard and adjusted anogenital distances

Diagnostic performance of PI-RADS and PSA density for detecting clinically significant prostate cancer

Cognitive zonal fusion biopsy of the prostate: Original technique between target and saturation

Free prostate-specific antigen outperforms total prostate-specific antigen as a predictor of prostate volume in patients without prostate cancer

Relevance of prostate cancer in patients with synchronous invasive bladder urothelial carcinoma: a monocentric retrospective analysis

Predictors of prostate cancer detection in MRI PI-RADS 3 lesions – Reality of a tertiary center

MRI/US fusion prostate biopsy in men on active surveillance: Our experience

Do all patients with suspicious prostate cancer need Multiparametric Magnetic Resonance Imaging before prostate biopsy?

The pathological and clinical features of anterior lesions of prostate cancer: Evaluation in a single cohort of patients

Outcomes of active surveillance for clinically localized prostate cancer in a middle eastern tertiary care center

Detection rate for significant cancer at confirmatory biopsy in men enrolled in Active Surveillance protocol: 20 cores vs 30 cores vs MRI/TRUS fusion prostate biopsy

Effectiveness of cognitive fusion transrectal ultrasound prostate biopsy when compared with final prostatectomy histology

Diagnostic accuracy of the Novel 29 MHz micro-ultrasound “ExactVuTM” for the detection of clinically significant prostate cancer: A prospective single institutional study. A step forward in the diagnosis of prostate cancer

MRI/TRUS FUSION guided biopsy as first approach in ambulatory setting: Feasibility and performance of a new fusion device

Incremental detection of clinically significant prostate cancer by systematic biopsy outside MRI-targeted lesions during cognitive fusion local anaesthetic transperineal biopsy

Can multiparametric ultrasound improve cognitive MRI/TRUS fusion prostate biopsy

Learning curve of a multidisciplinary team for magnetic resonance imaging/transperineal ultrasonography fusion prostate biopsy

Pathological issues in biopsy specimens of men with prostate cancer eligible for active surveillance

The effect of flavonoid and subclasses supplementation on prostate specific antigen, hormonal parameters and prostate cancer risk: a systematic review and meta-analysis of randomized controlled trials

Diagnostic efficacy and safety of transperineal prostate targeted and systematic biopsy: The preliminary experience of first 100 cases

Perineural invasion in prostate needle biopsy: Prognostic value on radical prostatectomy and active surveillance

mpMRI PI-RADS score 3 lesions diagnosed by reference vs affiliated radiological centers: Our experience in 950 cases

68Ga-PSMA PET/CT evaluation in men enrolled in prostate cancer Active Surveillance

Survival and oncological outcomes for young men (≤55 years) undergoing radical prostatectomy for localized prostate cancer

Multiparametric MRI targeted prostate biopsy: When omit systematic biopsy?

Prognostic value of neutrophil-to-lymphocyte ratio in mCRPC patients treated with abiraterone, enzalutamide and docetaxel: a retrospective single-center study

authors

reviewers

indexing